Clinical presentation and outcomes of patients with biliary malignancies: The Aga Khan university experience

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 3, 2009, Pages 463-466

  Kumar, Shiyam ^a   Masood, Nehal ^b   Shaikh, Asim Jamal ^b   Valimuhammad, Azmina T ^b   Haider, Ghulam ^c   Lal, Amar ^d   Niamatullah, Najeeb ^b  

^a Liaqat National Hospital   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^c JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^d TAWAM HOSPITAL   (United Arab Emirates)

Author keywords

Clinical details; Gallbladder cancer; Symptoms

Indexed keywords

EID: 75149165945     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Barakat J, Dunkelberg JC, Ma T (2006). Changing patterns of gallbladder carcinoma in New Mexico. Cancer, 106, 434-40.
2. Batra Y, Pal S, Dutta U, et al (2005). Gallbladder cancer in India: a dismal picture. J Gastroenterol Hepatol, 20, 309-14.
3. Bhurgri Y, Bhurgri A, Hasan SH, et al (2002). Cancer patterns in Karachi division (1998-1999). J Pak Med Assoc, 52, 244-6.
4. Chih Jung Shieh, EDJES (1981). Primary carcinoma of the gallbladder: A review of a 16-year experience at the waterbury hospital health center. Cancer, 47, 996-1004.
5. de Groen, P. C., G. J. Gores, LaRusso NF, et al. (1999). Biliary tract cancers. N Engl J Med, 341, 1368-78.
6. Kapoor VK, McMichael AJ (2003). Gallbladder cancer: an 'Indian' disease. Natl Med J India, 16, 209-13.
7. Kumar S, Kumar S, Kumar S, et al (2006). Infection as a risk factor for gallbladder cancer. J Surg Oncol, 93, 633-9.
8. Malik IA, Aziz Z, Zaidi SH, et al (2003). Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am J Clin Oncol, 26, 174-7.
9. Malik KA (2006). Pattern of gall bladder disease at Nawab Shah : An analysis of 260 patients. Pak J Surg, 22, 211-214.
10. Nawaz T (2000). Incidence of carcinoma gall bladder in cholelithiasis. Pak J Surg, 16, 33-5.
11. Patt YZ, Hassan MM, Aguayo A, et al (2004). Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer, 101, 578-86.
12. Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602.
13. Rizvi TJ, Zuberi SJ (2003). Risk factors for gall bladder cancer in Karachi. J Ayub Med Coll Abbottabad, 15, 16-8.
14. Roa I, Ibacache G, Roa J (2006). Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer: a case-control study. J Surg Oncol, 93, 624-8.
15. Shukla VK, Khandelwal C, Roy SK, et al (1985). Primary carcinoma of the gall bladder: a review of a 16-year period at the University Hospital. J Surg Oncol, 28, 32-5.
16. Thongprasert S, Napapan S, Charoentum C, et al (2005). Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol, 16, 279-81.
17. Zahir N, Mubarik A, Parveen A, et al (2000). Pattern of malignant tumors in Karachi-is it different? J Coll Physicians Surg Pak, 10, 338-41.